scholarly article | Q13442814 |
P50 | author | Hubert Erich Blum | Q20742669 |
Manfred Weidmann | Q24750172 | ||
Carl Jorns | Q50222457 | ||
Dirk Holzinger | Q55572028 | ||
Otto Haller | Q87800237 | ||
P2093 | author name string | Georg Kochs | |
Robert Thimme | |||
Hans Christian Spangenberg | |||
Jens Rasenack | |||
P2860 | cites work | Measurement of MxA mRNA or protein as a biomarker of IFNbeta bioactivity: detection of antibody-mediated decreased bioactivity (ADB). | Q35580819 |
Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter | Q40650459 | ||
MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon | Q40703041 | ||
Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway | Q43030367 | ||
Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q43034904 | ||
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection | Q45776314 | ||
P433 | issue | 1 | |
P921 | main subject | virology | Q7215 |
antibody | Q79460 | ||
hepatitis C | Q154869 | ||
chronic hepatitis C | Q55779873 | ||
chronic hepatitis | Q62019625 | ||
P304 | page(s) | 74-82 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Journal of Medical Virology | Q15716684 |
P1476 | title | Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-α | |
P478 | volume | 78 |
Q38818595 | A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner |
Q50551142 | Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C. |
Q40472668 | Assessment of a novel recombinant vesicular stomatitis virus with triple mutations in its matrix protein as a vaccine for pigs. |
Q39445369 | Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2. |
Q33892350 | Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. |
Q36269957 | Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication |
Q45362979 | Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus |
Q47317507 | Frequently used bioinformatics tools overestimate the damaging effect of allelic variants. |
Q34416678 | Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response |
Q37452450 | Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. |
Q34391514 | Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia Baré. |
Q46957326 | IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population. |
Q38301869 | Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling |
Q37352688 | Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses |
Q104437358 | Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV |
Q107112050 | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV |
Q30361157 | Multiple anti-interferon actions of the influenza A virus NS1 protein |
Q43000916 | Neutralizing antibodies to interferon‐α and circulating interferon in patients with chronic hepatitis C non‐responding to pegylated interferon plus ribavirin re‐treated by pegylated interferon‐α‐2a and ribavirin (ANRS HC16 GAMMATRI substudy*) |
Q38859862 | Orf virus inhibits interferon stimulated gene expression and modulates the JAK/STAT signalling pathway |
Q39461698 | Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane |
Q38926063 | Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes |
Q33435810 | Safety, Tolerability, and Immunogenicity of Interferons |
Q35000926 | Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene |
Q34082151 | The early interferon alpha subtype response in infant macaques infected orally with SIV. |
Q34055431 | Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles |
Q40844750 | Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells. |
Q55097752 | Viral targeting of TFIIB impairs de novo polymerase II recruitment and affects antiviral immunity. |
Search more.